ISIN | LU1683285750 |
---|---|
Valorennummer | 38312183 |
Bloomberg Global ID | BBG000KJFX60 |
Fondsname | UBS (Lux) Digital Health Equity Fund IB USD |
Fondsanbieter |
Credit Suisse Fund Management S.A.
Zürich, Schweiz Telefon: +41 44 333 40 50 E-Mail: clientservices.amfunds@credit-suisse.com Web: www.credit-suisse.com |
Fondsanbieter | Credit Suisse Fund Management S.A. |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) |
UBS AG Basel Telefon: +41 61 288 75 01 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Equity Health Care |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Ausgabekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Konditionen bei der Rücknahme | Rücknahmekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Investment-Strategie *** | The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities. |
Besonderheiten |
Aktueller Preis * | 702.58 USD | 21.11.2024 |
---|---|---|
Vorheriger Preis * | 699.56 USD | 20.11.2024 |
52 Wochen Hoch * | 780.14 USD | 27.02.2024 |
52 Wochen Tief * | 639.37 USD | 30.11.2023 |
NAV * | 702.58 USD | 21.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 1'001'210'494 | |
Anteilsklassevermögen *** | 81'690'543 | |
Trading Information SIX |
YTD-Performance | -4.84% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD-Performance (in CHF) | +0.27% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 Monat | -2.51% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 Monate | -3.19% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 Monate | +0.94% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 Jahr | +10.97% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 Jahre | +1.15% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 Jahre | -36.90% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 Jahre | +6.50% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.5718 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 21.11.2024 |
Zai Lab Ltd Ordinary Shares | 4.30% | |
---|---|---|
Zealand Pharma AS | 3.96% | |
Exact Sciences Corp | 3.92% | |
Redcare Pharmacy NV | 3.89% | |
Natera Inc | 3.81% | |
Veeva Systems Inc Class A | 3.75% | |
Inspire Medical Systems Inc | 3.60% | |
Schrodinger Inc Ordinary Shares | 3.51% | |
Doximity Inc Class A | 3.46% | |
Denali Therapeutics Inc | 3.32% | |
Letzte Daten-Aktualisierung | 31.10.2024 |
TER | 1.15% |
---|---|
Datum TER | 31.05.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.20% |
Ongoing Charges *** | 1.15% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |